The presence of an inflammatory response in the B16 melanomas treated with LTX-315 was further indicated by increased mRNA levels of inflammatory cytokines such as interleukin (IL) 1β, IL6 and IL18 in the tumor tissue and of IL6 in plasma samples. This evidence concerns the gene IL6 and neoplasm.